Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: ringing in my ear/having buzz, ring in both ears; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient received BNT162b2 (BNT162B2), on 04Oct2021 at 10:00 as dose 3 (booster), single (Lot number: FF2588) at the age of 71 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Allergy: sulpha" (unspecified if ongoing); "Blood pressure" (ongoing); "Cholesterol" (ongoing); "Breast cancer", start date: 15Apr1991 (unspecified if ongoing), notes: 6 months chemo, 5 years tamoxin; "Mastectomy" (unspecified if ongoing). Concomitant medication(s) included: ALEVE; BABY ASPIRIN; STATIN [NYSTATIN]; LISINOPRIL AND HYDROCHLORTIAZIDE taken for blood pressure measurement, start date: 2012 (ongoing); ATENOLOL taken for blood pressure measurement (ongoing); ATORVASTATIN taken for blood cholesterol (ongoing); FLU, start date: 21Oct2021. Vaccination history included: BNT162b2 (Dose 1, Single, Strength: 0.3 ML, Batch/Lot No: EN6199, Location of injection: Right arm, Vaccine Administration Time: 10:00 AM), administration date: 09Mar2021, when the patient was 70-year-old, for Covid-19 Immunization; BNT162b2 (Dose 2, Single, Strength: 0.3 ML, Batch/Lot No: ER8732, Location of injection: Right arm, Vaccine Administration Time: 10:00 AM), administration date: 30Mar2021, when the patient was 70-year-old, for Covid-19 Immunization. The following information was reported: TINNITUS (non-serious) with onset 04Nov2021, outcome "not recovered", described as "ringing in my ear/having buzz, ring in both ears". The event "ringing in my ear/having buzz, ring in both ears" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of tinnitus.  Additional Information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Specific relevant test for thromboembolic events with thrombocytopenia was None. The patient saw ear doctor (address withheld) on 17Mar2022 and was having buzz, ring in both ears. Thought had an electrical problem in house sounded loud and lasted all the time. Seemed better when not silent. Dr. checked ears and said No cure for tinnitus. May be hearing aids had hearing test too.  No follow-up attempts are possible. No further information is expected.  Follow-up (11Apr2022): This is a follow up-spontaneous report from a contactable consumer. This female consumer (patient) reported in response to consumer letter sent via follow-up letter which included that:  Updated information: For primary reporter email added. New reporter added in slider#02, Historical vaccine added, For historical vaccines first and second dose anatomical site added in notes field, Relevant Medical History added, New laboratory test results for Ear test and hearing exam performed on 17Mar2022 added, For suspect product anatomical location updated, Vaccination facility name and type added per provided for third dose, Concomitant coded, New event added, and Additional information added.